Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Frontiers in Neurology|August 31, 2018
Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical TrialAzadeh Agahi, Gholam Ali Hamidi, Reza Daneshvar, et al.
Annals of Nuclear Medicine|May 7, 2026
Fibroblast activation protein-targeted molecular imaging in interstitial lung disease: a systematic reviewAli Ghorbani Olya, Mehrzad Bahtouee, Esmail Jafari, et al.
The Neuroradiology Journal|July 5, 2021
A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19)Bahar Bahranifard, Somayeh Mehdizadeh, Ali Hamidi, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|March 20, 2014
Effectiveness of tamsulosin in prevention of post-operative urinary retention: a randomized double-blind placebo-controlled studyAli Hamidi Madani, Hamidreza Baghani Aval, Gholamreza Mokhtari, et al.
Journal of Diabetes and Metabolic Disorders|November 17, 2023
Evaluation of the frequency of metabolic syndrome and assessment of cardiometabolic index among men with erectile dysfunction: a prospective cross-sectional studyAli Hamidi Madani, Ardalan Akhavan, Mohammad Hamidi Madani, et al.
Scientific Reports|January 9, 2021
Gamma-radiated immunosuppressed tumor xenograft mice can be a new ideal model in cancer researchHamid Khodayari, Saeed Khodayari, Solmaz Khalighfard, et al.
BJU International|February 22, 2012
Treatment of loin pain suspected to be renal colic with papaverine hydrochloride: a prospective double-blind randomised studySeyed Alaeddin Asgari, Mani Mohiti Asli, Ali Hamidi Madani, et al.
The Lancet. Oncology|September 11, 2025
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b studyKelly G Paulson, Sally C M Lau, Myung-Ju Ahn, et al.
The Oncologist|March 29, 2025
Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinomaJoel Randolph Hecht, Arjun Oberoi, Elena Garralda Cabanas, et al.
Oncology and Therapy|September 4, 2025
Asian Subgroup Analysis of Patients in the Phase 2 DeLLphi-301 Study of Tarlatamab for Previously Treated Small Cell Lung CancerMyung-Ju Ahn, Byoung Chul Cho, Kadoaki Ohashi, et al.
Pageof 6